Contrary to what we previously observed in BC cohorts containing tumors of all intrinsic subtypes [4], in which ECM3 tumors were mainly ER positive and grade I-II, ECM3 was not significantly associated with any clinico-pathological variable in all the datasets analyzed (Table 1).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}